<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00661063</url>
  </required_header>
  <id_info>
    <org_study_id>042/2007</org_study_id>
    <nct_id>NCT00661063</nct_id>
  </id_info>
  <brief_title>Diabetic Neuropathy Topical Treatment</brief_title>
  <official_title>Diabetic Neuropathic Pain Topical Treatment- Comparative Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Irmandade da Santa Casa de Misericordia de Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Irmandade da Santa Casa de Misericordia de Sao Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparative study of efficacy and safety of ketamine, clonidine, mixture of both and placebo
      in patients with diabetic neuropathic pain
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>April 2008</start_date>
  <completion_date type="Anticipated">June 2009</completion_date>
  <primary_completion_date type="Anticipated">April 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain evaluation by visual analogue scale</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>pain evaluation by amount of rescue medication required</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Diabetic Neuropathy</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>K</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>drug - ketamine 1% gel</description>
  </arm_group>
  <arm_group>
    <arm_group_label>P</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>vehicle gel</description>
  </arm_group>
  <arm_group>
    <arm_group_label>M</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>association of ketamine and clonidine gel</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>clonidine gel</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ketamine</intervention_name>
    <description>ketamine 150 mcg/g bid</description>
    <arm_group_label>K</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>vehicle gel</intervention_name>
    <description>bid - 12 weeks</description>
    <arm_group_label>P</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ketamine + clonidine</intervention_name>
    <description>ketamine 150mcg/g + clonidine 1% gel bid 12 weeks</description>
    <arm_group_label>M</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>clonidine gel 1%</intervention_name>
    <description>bid 12 weeks</description>
    <arm_group_label>C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diabetes Mellitus type I or II

          -  Mono or polyneuropathy

          -  Treatment with Tricyclic Antidepressant, Carbamazepine during 3 weeks at least

          -  Preserved cognition

        Exclusion Criteria:

          -  Ulcerative or infection or vesicle lesion in pain site

          -  Pregnancy

          -  Breast feeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Judymara L Gozzani, Investigator</last_name>
    <role>Principal Investigator</role>
    <affiliation>Santa Casa de São Paulo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Judymara L Gozzani, investigator</last_name>
    <phone>55-11-3884-0865</phone>
    <email>gozzani@osite.com.br</email>
  </overall_contact>
  <location>
    <facility>
      <name>Santa Casa de São Paulo</name>
      <address>
        <city>São Paulo</city>
        <zip>01277-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>April 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 15, 2008</study_first_submitted>
  <study_first_submitted_qc>April 17, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2008</study_first_posted>
  <last_update_submitted>April 17, 2008</last_update_submitted>
  <last_update_submitted_qc>April 17, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 18, 2008</last_update_posted>
  <responsible_party>
    <name_title>Judymara Lauzi Gozzani PhD</name_title>
    <organization>ISCMSP</organization>
  </responsible_party>
  <keyword>neuropathic pain</keyword>
  <keyword>ketamine</keyword>
  <keyword>clonidine</keyword>
  <keyword>association</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetic Neuropathies</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Clonidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

